Your browser doesn't support javascript.
loading
Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach.
Nyberg, Fredrik; Askling, Johan; Berglind, Niklas; Franzén, Stefan; Ho, Meilien; Holmqvist, Marie; Horne, Laura; Lampl, Kathy; Michaud, Kaleb; Pappas, Dimitrios A; Reed, George; Symmons, Deborah; Tanaka, Eiichi; Tran, Trung N; Verstappen, Suzanne M M; Wesby-van Swaay, Eveline; Yamanaka, Hisashi; Greenberg, Jeffrey D.
Afiliação
  • Nyberg F; Medical Evidence & Observational Research Centre, Global Medicines Development, AstraZeneca R&D, Mölndal, Sweden.
  • Askling J; Occupational and Environmental Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Berglind N; Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Franzén S; Department of Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
  • Ho M; Biometric & Information Sciences, Global Medicines Development, AstraZeneca R&D, Mölndal, Sweden.
  • Holmqvist M; Biometric & Information Sciences, Global Medicines Development, AstraZeneca R&D, Mölndal, Sweden.
  • Horne L; Clinical, Global Medicines Development, AstraZeneca R&D, Macclesfield, UK.
  • Lampl K; Clinical Epidemiology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Michaud K; Medical Evidence & Observational Research Centre, Global Medicines Development, AstraZeneca, Wilmington, DE, USA.
  • Pappas DA; Clinical, Global Medicines Development, AstraZeneca, Wilmington, DE, USA.
  • Reed G; University of Nebraska Medical Center, Omaha, NE, USA.
  • Symmons D; National Data Bank for Rheumatic Diseases, Wichita, KS, USA.
  • Tanaka E; The College of Physicians and Surgeons, Columbia University Medical Center, New York, NY, USA.
  • Tran TN; University of Massachusetts Medical School, Worcester, MA, USA.
  • Verstappen SM; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Wesby-van Swaay E; Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, UK.
  • Yamanaka H; Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan.
  • Greenberg JD; MedImmune, Gaithersburg, MD, USA.
Pharmacoepidemiol Drug Saf ; 24(11): 1121-32, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26303866
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Desenho de Fármacos / Sistema de Registros / Antirreumáticos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Desenho de Fármacos / Sistema de Registros / Antirreumáticos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article